O-1602 from Tocris Bioscience, a Bio-Techne Brand

Product Specs
ItemO-1602
CompanyTocris Bioscience, a Bio-Techne Brand
Price $294.00Supplier Page View Company Product Page
Catalog Number2797/10
Quantity10 mg
Purity97%
Molecular Weight258.36
Molecule Name5-Methyl-4-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-1,3-benzenediol
FormulaC17H22O2
StorageStore at -20°C

Sizes Available: 10 mg

614 McKinley Place N.E.

Minneapolis, Minnesota 55413

United States

Phone: 1 (800) 343-7475
1 (612) 379-2956
Fax: 1 (612) 656-4400

(1) Anti-neuroinflammatory effects of GPR55 antagonists in LPS-activated primary microglial cellsJournal of neuroinflammationNovember 19, 2018Saliba SW, Jauch H, Gargouri B, Keil A, Hurrle T, Volz N, Mohr F, van der Stelt M, Bräse S, Fiebich BL.

(3) Activation of GPR55 increases neural stem cell proliferation and promotes early adult hippocampal neurogenesisBritish journal of pharmacologyAugust 1, 2018Hill JD, Zuluaga-Ramirez V, Gajghate S, Winfield M, Persidsky Y.

(6) Addition of lysophospholipids with large head groups to cells inhibits Shiga toxin bindingScientific reportsJuly 26, 2016Ailte I, Lingelem AB, Kavaliauskiene S, Bergan J, Kvalvaag AS, Myrann AG, Skotland T, Sandvig K.

(7) Modulation of breast cancer cell viability by a cannabinoid receptor 2 agonist, JWH-015, is calcium dependentBreast cancer (Dove Medical Press)January 1, 2016Hanlon KE, Lozano-Ondoua AN, Umaretiya PJ, Symons-Liguori AM, Chandramouli A, Moy JK, Kwass WK, Mantyh PW, Nelson MA, Vanderah TW.

(8) Δ(9)-Tetrahydrocannabinol treatment during human monocyte differentiation reduces macrophage susceptibility to HIV-1 infectionJournal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune PharmacologyJune 1, 2014Williams JC, Appelberg S, Goldberger BA, Klein TW, Sleasman JW, Goodenow MM.

(9) A role for the putative cannabinoid receptor GPR55 in the islets of LangerhansThe Journal of endocrinologyNovember 1, 2011Romero-Zerbo SY, Rafacho A, Díaz-Arteaga A, Suárez J, Quesada I, Imbernon M, Ross RA, Dieguez C, Rodríguez de Fonseca F, Nogueiras R, et al.

(10) The atypical cannabinoid O-1602 protects against experimental colitis and inhibits neutrophil recruitmentInflammatory bowel diseasesAugust 1, 2011Schicho R, Bashashati M, Bawa M, McHugh D, Saur D, Hu HM, Zimmer A, Lutz B, Mackie K, Bradshaw HB, et al.

O-1602